Has Naba Saeed, MD received payments from drug or device companies?

Yes. Drug and device makers reported $802 in general payments to Naba Saeed, MD across 37 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Naba Saeed, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Naba Saeed, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Naba Saeed, MD

Gastroenterology · Georgetown, KYNPI 1558712257

Payments from drug & device makers

$802in general payments, 2019–2025

Across 37 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$388
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$103
Pentax Of America, Inc.$69
Johnson & Johnson$35
Micro-tech Endoscopy USA, Inc.$35
Takeda Pharmaceuticals U.S.A., Inc.$33
plus $138 from 6 others

What the payments were for

Food & beverage$802100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	19	$388
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$103
Pentax Of America, Inc.	1	$69
Johnson & Johnson	2	$35
Micro-tech Endoscopy USA, Inc.	1	$35
Takeda Pharmaceuticals U.S.A., Inc.	2	$33
Merck	2	$33
Mallinckrodt Hospital Products Inc.	1	$22
Phathom Pharmaceuticals, Inc.	1	$22
QOL Medical, LLC	1	$21
Intercept Pharmaceuticals, Inc.	1	$20
Sanofi	1	$19

How this compares

$802 in reported general payments places this provider in the 20th percentile of 207 gastroenterology providers in Kentucky.

See all gastroenterology providers in Kentucky →

Medicare billing

Part B allowed, 2024

$15,310

Medicare patients

Services billed

112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dexlansoprazole DrDexlansoprazole	13	$1,100
Omeprazole	64	$585
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	16	$272

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Georgetown

Gerald DrydenLouisville$3.5M
Michael JonesCrestview Hills$1.9M
Jens RosenauLexington$1.6M
Matthew CaveLouisville$916K
Deborah FlomenhoftLexington$905K
Michael KreaseLouisville$694K
Zahid SaeedCrestview Hills$442K
Thomas AbellLouisville$375K
Sunana SohiLouisville$220K
Jeffrey TuvlinLouisville$202K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →